NEW: PepMix Collections for SARS-CoV-2 Wuhan & Variants
Published on 22/06/2022
Throughout the pandemic, many SARS-CoV-2 variants have emerged, with some variants being of concern and others of interest, according to the WHO. We have continuously responded and made multiple PepMix overlapping peptide pools available of variant spike glycoproteins and all Wuhan proteins for cellular immune response profiling, T-cell monitoring, and epitope mapping.
We now announce the launch of our PepMix Collections for SARS-CoV-2, which cover all relevant antigens of either structural or non-structural viral proteins or spike glycoproteins belonging to so-far nine identified variants of concern:
- NEW: PepMix Collection SARS-CoV-2 Wuhan Structural Proteins
- NEW: PepMix Collection SARS-CoV-2 Wuhan Non-structural Proteins
- NEW: PepMix Collection SARS-CoV-2 S_RBD Mutations
- NEW: PepMix Collection SARS-CoV-2 Spike Mutations
We also offer PepMix collections for many other diseases, including common viral and bacterial infections, or different forms of cancer such as breast cancer, prostate cancer and melanoma.
Moreover, we now offer
all PepMix that cover antigens for SARS-CoV-2
wildtype structural and non-structural proteins with >70% purity.